Evidence map›Paper›PMID 39731019›Full record

ArticleBMC bioinformatics2024

AEGAN-Pathifier: a data augmentation method to improve cancer classification for imbalanced gene expression data.

Qiaosheng Zhang, Yalong Wei, Jie Hou, Hongpeng Li, Zhaoman Zhong

Abstract read
In one paragraph

Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiaosheng ZhangSchool of Computer Engineering, Jiangsu Ocean University, Lianyungang, 222005, China.
Yalong WeiSchool of Computer Engineering, Jiangsu Ocean University, Lianyungang, 222005, China. yalongwei@jou.edu.cn.
Jie HouPublic Teaching and Research Department, Huzhou College, Huzhou, 313000, China.
Hongpeng LiCollege of Science, Jiangsu Ocean University, Lianyungang, 222005, China.
Zhaoman ZhongSchool of Computer Engineering, Jiangsu Ocean University, Lianyungang, 222005, China.

Funding

Lianyungang Science and Technology Projects CG2223National Natural Science Foundation of China 72174079Postgraduate Research of Lianyungang LYG20210010
6 · The paper itself

Abstract

backgroundCancer classification has consistently been a challenging problem, with the main difficulties being high-dimensional data and the collection of patient samples. Concretely, obtaining patient samples is a costly and resource-intensive process, and imbalances often exist between samples. Moreover, expression data is characterized by high dimensionality, small samples and high noise, which could easily lead to struggles such as dimensionality catastrophe and overfitting. Thus, we incorporate prior knowledge from the pathway and combine AutoEncoder and Generative Adversarial Network (GAN) to solve these difficulties.

resultsIn this study, we propose an effective and efficient deep learning method, named AEGAN, which combines the capabilities of AutoEncoder and GAN to generate synthetic samples of the minority class in imbalanced gene expression data. The proposed data balancing technique has been demonstrated to be useful for cancer classification and improving the performance of classifier models. Additionally, we integrate prior knowledge from the pathway and employ the pathifier algorithm to calculate pathway scores for each sample. This data augmentation approach, referred to as AEGAN-Pathifier, not only preserves the biological functionality of the data but also possesses dimensional reduction capabilities. Through validation with various classifiers, the experimental results show an improvement in classifier performance.

conclusionAEGAN-Pathifier shows improved performance on the imbalanced datasets GSE25066, GSE20194, BRCA and Liver24. Results from various classifiers indicate that AEGAN-Pathifier has good generalization capability.

Indexed as

NeoplasmsAlgorithmsComputational BiologyDatabases, GeneticDeep LearningGene Expression ProfilingHumansDeep learningGenerative adversarial networkImbalanced dataPathifierPathway

Identifiers

PMID39731019
PMCPMC11673641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.